Source: Annual Congress 2002 - Prevalence and costs of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. C. Jonsson, A. Lindberg, S. A. Jansson, M. Lindström, S. Andersson, L. G. Larsson, E. Rönmark, B. Lundbäck (Luleå, Stockholm, Sweden). The proportion of non-symptomatic COPD is small. Eur Respir J 2002; 20: Suppl. 38, 824

Member's Comments

No comment yet.

Related content which might interest you: Out of proportion pulmonary hypertension(PH) in COPD Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Pathology of small airways in non-COPD smokers with low diffusion capacity and patients with COPD Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 Comparison of small airways disease measures between frequent and infrequent COPD exacerbators Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019 How common is exacerbations in COPD in a general population sample? Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD Year: 2010 The occurrence of COPD and small bronchi disease in welders Source: Eur Respir J 2002; 20: Suppl. 38, 324s Year: 2002 The clinical importance of small airway involvement in patients with asthma and COPD Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD Year: 2019 COPD exacerbations and predictors in a general population Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Ex-smokers with frequent COPD exacerbations have low FENO in stable condition Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 A retrospective cohort study demonstrating the impact of an OPEP device on exacerbations in COPD patients with chronic bronchitis Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD Source: Eur Respir J, 56 (5) 2003574; 10.1183/13993003.03574-2020 Year: 2020 Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD Source: Eur Respir J, 56 (5) 2003367; 10.1183/13993003.03367-2020 Year: 2020 The comparison of eosinophilic and non-eosinophilic  stable COPD patients Source: International Congress 2017 – Markers of COPD progression Year: 2017 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers Source: Eur Respir J 2015; 45: 828-831 Year: 2015 Frequency and impact of bronchiectasis in a cohort of patients in a COPD clinic Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 COPD patients continue to smoke after being diagnosed for COPD Source: Virtual Congress 2020 – The role of health care systems in treating tobacco dependence Year: 2020 Influence of bronchodilator usage for the cross-sectional area of small pulmonary vessels in COPD patients Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 The prevalence of undiagnosed COPD and approaches to promote early COPD diagnosis in lung cancer population Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Incidence of asthma and COPD in a general population Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD Year: 2010